Back to results
US 10,472,370 B2Granted
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7
AssigneeEli Lilly and Company
InventorCarlos Montero
Life of this patent
Estimating the term…
Abstract
The present invention provides novel CDK7 inhibitors and pharmaceutical compositions thereof: or a pharmaceutically acceptable salt thereof.
Claims14
A compound of formula (I):
- or a pharmaceutically acceptable salt or enantiomer thereof.
A pharmaceutical composition comprising one or more pharmaceutically acceptable carriers, diluents or excipients in combination with a compound of formula (I):
- or a pharmaceutically acceptable salt or enantiomer thereof.
Dependencies are inferred from the claim text.